Fatal Intracranial Hemorrhage With Belzutifan in von Hippel-Lindau Disease–Associated Hemangioblastoma: A Case Report

Article Tools CASE REPORTS Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/PO.23.00066 JCO Precision Oncology no. 7 (2023) e2300066. Published online June 1, 2023. PMID: 37262389 Fatal Intracranial Hemorrhage With Belzutifan in von Hippel-Lindau Disease–Associated Hemangioblastoma: A Case Report Zabila Saeed , MD1xZabila SaeedSearch for articles by this author, Azka Tasleem , MD1xAzka TasleemSearch for articles by this author, Ashok Asthagiri, MD2xAshok AsthagiriSearch for articles by this author; David Schiff , MD3xDavid SchiffSearch for articles by this authorand Jasmin Jo , MD1xJasmin JoSearch for articles by this author Show More 1Division of Hematology Oncology, Department of Internal Medicine, East Carolina University, Greenville, NC2Department of Neurological Surgery, University of Virginia, Charlottesville, VA3Division of Neuro-oncology, Department of Neurology, University of Virginia, Charlottesville, VA https://doi.org/10.1200/PO.23.00066 First Page Full Text PDF Figures and Tables © 2023 by American Society of Clinical OncologyAUTHOR CONTRIBUTIONSConception and design: All authorsProvision of study materials or patients: Ashok Asthagiri, David Schiff, Jasmin JoCollection and assembly of data: All authorsData analysis and interpretation: Ashok Asthagiri, David Schiff, Jasmin JoManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTThe following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/po/author-center.Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).David SchiffConsulting or Advisory Role: Orbus Therapeutics, GlaxoSmithKline, PRA, AstraZenecaResearch Funding: Bayer (Inst)Patents, Royalties, Other Intellectual Property: Receive royalties for submissions to UpToDateNo other potential conflicts of interest were reported.